Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature. by Saglietti, C. et al.
April 2017 | Volume 4 | Article 431
Original research
published: 24 April 2017
doi: 10.3389/fmed.2017.00043
Frontiers in Medicine | www.frontiersin.org
Edited by: 
Luca Di Tommaso, 
Humanitas Research Hospital, Italy
Reviewed by: 
Fernando Schmitt, 
Porto University, Portugal  
Venancio Avancini Alves, 
University of São Paulo, Brazil
*Correspondence:
Massimo Bongiovanni  
massimo.bongiovanni@chuv.ch
Specialty section: 
This article was submitted 
to Pathology, 
a section of the journal 
Frontiers in Medicine
Received: 02 February 2017
Accepted: 05 April 2017
Published: 24 April 2017
Citation: 
Saglietti C, Volante M, La Rosa S, 
Letovanec I, Pusztaszeri M, Gatti G 
and Bongiovanni M (2017) Cytology 
of Primary Salivary Gland-Type 
Tumors of the Lower Respiratory 
Tract: Report of 15 Cases and 
Review of the Literature. 
Front. Med. 4:43. 
doi: 10.3389/fmed.2017.00043
cytology of Primary salivary  
gland-Type Tumors of the lower 
respiratory Tract: report of 15 
cases and review of the literature
Chiara Saglietti1, Marco Volante2, Stefano La Rosa1, Igor Letovanec1, Marc Pusztaszeri3, 
Gaia Gatti 2 and Massimo Bongiovanni1*
1 Service of Clinical Pathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland,  
2 Department of Oncology, University of Turin at San Luigi Hospital, Turin, Italy, 3 Department of Pathology,  
Geneva University Hospital, Geneva, Switzerland
Primary pulmonary salivary gland-type tumors are rare neoplasms arising from the 
seromucinous submucosal glands of the lower respiratory tract (LRT), the most common 
of which are mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma. They are 
morphologically indistinguishable from their salivary gland counterpart and recognizing 
them is a challenge, especially on cytological specimens. We analyzed 15 cases of his-
tologically proven primary salivary gland tumors of the LRT to identify cytomorphological 
features and define potential diagnostic clues that might assist cytopathologists in the 
preoperative diagnosis of these neoplasias. Three out of the four cases of adenoid cystic 
carcinomas showed the characteristic tridimensional cell clusters and hyaline globules, 
whereas the last one did not show malignant cells; only two cases of MEC presented 
the three characteristic cell types (i.e., squamous, intermediate, and mucin secreting) 
on cytology. Since these neoplasms are rare and do not have a completely specific set 
of cytological features, it is important for practicing cytopathologists to be aware of the 
possibility of encountering them, in specimens from patients with LRT masses, in order 
to render the correct diagnosis.
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inTrODUcTiOn
Primary salivary gland-type tumors (PSGT) arising from the seromucinous submucosal glands of 
the lower respiratory tract (LRT) (which includes trachea, bronchus and lung) account for <1% of 
central airway carcinomas (1). They are rare neoplasms morphologically indistinguishable from 
their salivary gland counterpart; therefore, recognizing them is a challenge, especially on cytology. 
Even though any type of salivary gland tumor that has been described in pathology textbooks can 
potentially arise in the LRT, published data show that the most commonly encountered primary 
salivary gland-type tumors in this anatomical site are malignant mucoepidermoid carcinoma 
(MEC), adenoid cystic carcinoma (AdCC), and epithelial-myoepithelial carcinoma (2–5). In fact, 
as opposed to the head and neck region, where the vast majority of salivary gland primaries are 
benign—with pleomorphic adenoma (PA) being the most common type—the contrary applies to 
LRT primaries (1).
Cytological examination of fine-needle aspiration (FNA), bronchial aspiration (BA) or brush-
ing (BB), bronchoalveolar lavage (BAL), or even sputum has been shown to be a powerful tool for 
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the diagnosis of lung cancer, particularly when it presents as an 
endobronchial growth. Moreover, in recent years, endobronchial 
ultrasound-guided transbronchial needle aspiration (EBUS-
TBNA) has emerged as the standard of care for the diagnosis and 
staging of lung cancer and has been successfully implemented 
into daily clinical practice. EBUS-TBNA is minimally invasive, 
safe, cost-effective, and particularly useful in diagnosing centrally 
located lung lesions (6).
All the aforementioned cytological procedures are useful 
for collecting material for cytological examination, immunocy-
tochemistry (ICC), fluorescent in  situ hybridization (FISH), or 
molecular analyses, which may be relevant for diagnosis and 
targeted therapy. Moreover, in 30% of cases, cytological material 
is the only material available for pulmonary malignancies and 
proper classification of the lesions, often with subtyping, is fun-
damental for adequate patient management.
We describe 15 cases of histologically proven PSGT of the LRT; 
all but two were misdiagnosed on preoperative cytology. We have 
tried to identify cytomorphological features that could point to a 
correct cytological diagnosis. To the best of our knowledge, this is 
the largest cytological series of PSGT of the LRT ever published.
MaTerials anD MeThODs
case selection
Nineteen cases of surgically resected PSGT originating from the 
trachea, main bronchi, and lung with corresponding preoperative 
cytology were identified by searching the databases of our institu-
tions (Service of Clinical Pathology, Lausanne University Hospital; 
Department of Pathology, Geneva University Hospital; Section of 
Anatomic Pathology, San Luigi Hospital, Orbassano, Turin) over 
a period of 21  years (1995–2015). Cytological and histological 
specimens of each case were retrieved from the archives to be 
reviewed for adequacy. Three cases were excluded because slides 
were no longer available for revision, and one case was excluded 
because it originated from the larynx and not from the LRT. The 
database was also investigated to exclude the presence of primary 
salivary gland tumors that could have metastasized to the LRT.
The study cohort of the present work was thus composed of 
15 cases. Clinical, radiological, and pathological reports for each 
patient were analyzed to collect pertinent information, including 
age, gender, alcohol and smoking history, presenting symptoms 
and signs, radiological findings, tumor size, and original preop-
erative cytological diagnosis.
cytomorphological Features
All cytological smears were reviewed by an expert cytopathologist 
(Massimo Bongiovanni) to evaluate the presence of cytomorpho-
logical features that could have pointed to a correct preoperative 
diagnosis, namely: the presence of mucin and the three different 
neoplastic cellular components (mucin secreting, squamous, and 
intermediate) characteristic of MEC (3); organoid cell clusters, 
hyaline globules, cellular uniformity, and granular cytoplasm 
distinguishing AdCC (7). Particular attention was paid to look 
either cytologically or histologically for some of the newly 
described entities of salivary gland tumors, namely the mammary 
analog secretory carcinoma (MASC), the cribriform adenocarci-
noma of the tongue, and minor salivary gland (CATS) that so far 
have never been described in the LRT (8).
resUlTs
clinicopathological Findings
A summary of all relevant clinical, radiological, and pathological 
data of the patients are presented in Table 1. Patients ranged in 
age from 16 to 87 years (mean 59.6 ± 18.6 years); there were nine 
males and six females. From histology, 11 cases were diagnosed 
as MEC (5 low grade and 6 high grade), and the remaining four 
cases were diagnosed as AdCC according to the histological 
criteria defined by the current WHO classification (3, 4).
The cytological slides that were revised included: 12 BA, 7 BB, 
5 BAL, and 1 FNA. More than one type of cytological sample 
was available for 6 out of the 15 cases (Table 1). The smears were 
either alcohol-fixed, Papanicolaou (PAP) stained or air dried, 
May-Grünwald-Giemsa (MGG) stained. Neither FISH analysis 
nor molecular studies were originally performed.
Tumors were all centrally located and ranged in size from 
1.7 to 5.0  cm (mean 4.4 ±  1.2  cm). Only one AdCC and one 
MEC were somehow identified preoperatively: the AdCC was 
diagnosed as a salivary gland-type neoplasia and the MEC as 
a non-small cell lung carcinoma, consistent with MEC. Five 
preoperative cytological cases were originally reported as nega-
tive for malignant cells (33.3%) (1 AdCC and 4 MEC), and this 
diagnosis was confirmed after revision of the slides in four out 
of five cases. Revised cytological diagnosis of the fifth case was 
that of an adenocarcinoma (concerning the BA specimen only). 
Interestingly, one AdCC was misdiagnosed as a metastatic breast 
carcinoma (due to the previous history of ductal breast carcinoma 
in the patient). During revision of the slides, all three diagnostic 
cases of AdCC showed the characteristic tridimensional cell 
clusters and hyaline globules that permit the cytological diagnosis 
of this entity, whereas only two cases of MEC presented the three 
characteristic cell types (i.e., squamous, intermediate, and mucin 
secreting) on cytology.
DiscUssiOn
Cytology has proven to be a powerful tool for the diagnosis of 
primary lung cancer. A summary of all published cases of PSGT 
of the LRT for which a cytological diagnosis is available in the 
literature is provided in Table 2. Exfoliative cytology, in particular 
bronchial brushing, aspiration, and washing, is especially useful 
for tumors with endobronchial growth. PSGT of the LRT, because 
of their origin from the submucosal bronchial glands, mainly 
present as endobronchial masses (1), and therefore, they are 
considered as accessible for cytological sampling and diagnosis. 
However, as previously reported by other authors, primary 
pulmonary AdCCs and MECs are usually covered by intact res-
piratory epithelium; therefore, FNA may be more effective than 
exfoliative cytology in diagnosis for some of such cases (9, 10). 
The results from our study confirm that when using exfoliative 
cytology only, a significant proportion of PSGT of the LRT cases 
(33%) do not yield diagnostic tumor cells.
Table 1 | clinicopathological and radiological data of our patients.
no. sex age alcohol/
smoking
relevant clinical 
findings
radiology/
bronchoscopy findings
site lesion 
size (cm)
Preoperative cytology histologic 
diagnosis
revised cytological 
diagnosis
BA BB BAL
1 F 64 NA/NA NA Distal carinal stenosis Carina 2.5 Salivary gland-type 
neoplasia
NP NP AdCC AdCC
2 F 74 NA/NA History of breast ductal 
carcinoma
Bronchial polypoid mass Right main bronchus 4.5 Metastatic breast carcinoma NP AdCC AdCC
3 M 70 NA/no NA Lung mass Right superior lobe 1.7 Absence of malignant 
cells
NP NP AdCC Absence of malignant 
cells
4 F 75 NA/NA Weakness, non- 
productive cough
NA NA NA (bioptic 
material 
only)
Suspicious for carcinoma NP NP AdCC AdCC
5 M 87 No/no Fall with costal fracture, 
hemorrhagic pleural 
effusion
Mass lesion with bronchial 
stenosis and atelectasis
Right lung 2.0 PDC NP MEC (low-grade) PDC
6 F 49 Yes/yes Weight loss, dyspnea, 
retrosternal pain
Lung mass Left upper lobe 3.5 Atypical squamous cells NP NP MEC (low-grade) PDC
7 F 65 No/no Weakness, productive 
cough, hemoptysis
Parahilar mass with 
atelectasis
Left upper lobe 2.6 PDC NP NP MEC (high-grade) PDC
8 M 75 No/yes Progressive dyspnea,  
non-productive cough
Bronchial stenosis Left main bronchus 4.0 Suspicious for carcinoma NP NP MEC (high-grade) PDC
9 M 60 Yes/yes Ongoing cough Peribronchial mass lesion Left inferior lobe 
bronchus
5.0 NP Adenocarcinoma NP MEC (high-grade) PDC
10 M 57 NA/NA NA Lung nodule Medium lobe 2.0 Absence of malignant cells MEC (low-grade) Adenocarcinoma (for 
the BA specimen only)
11 M 35 NA/NA NA Extrinsic bronchial 
compression
Apical bronchus of 
right superior lobe
5.0 NP Absence of malignant 
cells
MEC (high-grade) Absence of malignant 
cells
12 M 37 NA/NA NA Lung mass Segmental bronchus 
of right superior lobe
2.0 NP NSCLC, compatible  
with MEC
MEC (high-grade) NSCLC, compatible 
with MEC
13 M 76 NA/yes NA Apical nodule hypermeta-
bolic at PET scan
Left inferior lobe 2.5 Absence of malignant cells MEC (high-grade) Absence of malignant 
cells
14 M 16 No/no Progressive dyspnea, 
cough
NA NA NA (bioptic 
material 
only)
Absence of malignant 
cells
NP NP MEC (low-grade) Absence of malignant 
cells
15 F 54 NA/NA Pleural effusion NA NA NA (bioptic 
material 
only)
Suspicious for 
carcinoma, NOS
NP NP MEC (low-grade) NSCLC, compatible 
with MEC
AdCC, adenoid cystic carcinoma; MEC, mucoepidermoid carcinoma; BA, bronchial aspiration; BB, bronchial brushing; BAL, bronchoalveolar lavage; PDC, poorly differentiated carcinoma; NSCLC, non-small cell lung cancer; NA, not 
available; NP, not performed.
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Table 2 | summary of all reported cases of primary salivary gland-type tumors of the lower respiratory tract for which cytological diagnosis is available in the literature.a
reference sex age Presentation radiology 
findings
bronchoscopy 
findings
site lesion 
size 
(cm)
Preoperative cytology Frozen 
section
histologic 
diagnosis
FNA (TT) FNA (TM) BB BW/TW Sputum
Tao and Robertson (9) 
pt no. 1
F 46 Cough, shortness of 
breath, decreased 
energy
Well-
circumscribed, 
round lesion (CT)
Mass occluding 
the right upper 
lobe bronchus
Right hilum 3 MEC NA NA NA Negative for 
malignancy
NA MEC
Tao and Robertson (9) 
pt no. 2
F 54 Incidental finding on 
chest X-ray
Coin lesion  
(chest X-ray)
NA Right upper lobe NA MEC NA NA NA NA NA MEC 
(low-grade)
Lozowski et al. (10) pt 
no. 1
F 40 Productive cough, 
fever, chills,  
headache, lethargy
Consolidative 
pneumonitis of  
left lower lobe
Polypoid friable 
tumor
Left main stem 
bronchus, carinal 
level
NA NA NS Negative for 
malignancy
AdCC AdCC AdCC AdCC
Nguyen (11) pt no. 1 M 50 Cough, hemoptysis NA NA Tracheal 
carina + stem 
bronchi
NA NA NA NA NA AdCC NA AdCC
Nguyen (11) pt no. 2 F 36 Cough, hemoptysis NA NA Left stem  
bronchus
NA NA AdCC AdCC NA Positive for 
malignancy
NA AdCC
Nguyen (11) pt no. 3 M 48 Persistent cough NA NA Tracheal 
carina + stem 
bronchi
NA NA MEC 
(low-grade)
Negative for 
malignancy
NA Negative for 
malignancy
NA MEC 
(low-grade)
Nguyen (11) pt no. 4 F 29 Persistent cough NA NA Left stem  
bronchus
NA NA MEC 
(low-grade)
Negative for 
malignancy
NA Negative for 
malignancy
NA MEC 
(low-grade)
Nguyen (11) pt no. 5 M 80 Cough, hemoptysis, 
weight loss
NA NA Right upper lobe 
bronchus
NA Adeno-
squamous 
carcinoma
NA Positive for 
malignancy
NA Negative for 
malignancy
NA MEC 
(high-grade)
Buchanan et al. (12) 
pt no. 1
M 23 Substernal  
discomfort, choking 
sensation, wheezing, 
productive cough
Normal chest 
X-ray
Obstructing  
tumor
Trachea NA NA NA NA AdCC NA NA AdCC
Buchanan et al. (12) 
pt no. 2
F 51 Cough, wheezing, 
intermittent breathing 
difficulties
Spherical mass NA Trachea 1 NA NA NA AdCC Negative for 
malignancy
NA AdCC
Gupta and 
McHutchison (13) pt 
no. 1
F 85 Increasing shortness 
of breath, productive 
cough
NA Endotracheal 
tumor
Midtrachea NA NA NA NA AdCC NA NA AdCC
Brooks and Baandrup 
(14) pt no. 1
M 66 Incidental finding on 
chest X-ray
Peripheral lung 
mass
NA Right lower lobe 4 NA NA Negative for 
malignancy
NA NA NA MEC
Radhika et al. (15) pt 
no. 1
M 45 Progressive 
breathlessness, 
productive cough
Collapse of the 
right lung
Tumor at the 
carina extending 
in the bronchi
Carina + adjacent 
stem bronchi
NA NA NA NA AdCC NA NA AdCC
Segletes et al. (16) pt 
no. 1
M 47 Chronic pneumonia, 
increasing cough
Central right  
upper lobe mass
NA Right upper lobe NA MEC NA NA NA NA NA MEC
Segletes et al. (16) pt 
no. 2
M 72 Incidental finding on 
chest X-ray
Left lung mass 
extending into  
the chest wall
NA Left lung NA Consistent 
with MEC
NA NA NA NA NA MEC
Segletes et al. (16) 
pt no. 3
M 16 Pneumonia, cough, 
earache, weight loss
Mediastinal 
mass with 
enlarged lymph 
nodes
NA Right main stem 
bronchus
4 NA NA NA NA NA NA MEC
(Continued)
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Table 2 | continued
reference sex age Presentation radiology 
findings
bronchoscopy 
findings
site lesion 
size 
(cm)
Preoperative cytology Frozen 
section
histologic 
diagnosis
FNA (TT) FNA (TM) BB BW/TW Sputum
Segletes et al. (16) pt 
no. 4
F 25 NA NA Tumor in the 
bronchial lumen
NA NA NA AdCC NA NA AdCC
Delpiano et al. (17) pt 
no. 1
M 52 Cough, hemoptysis Coin lesion 
upper lobe of 
left lung
Reddish 
cauliflower-like 
lesion
Upper left lobe 
bronchus
NA NA NA Papillary 
structures 
lined by 
cuboidal-
to-columnar 
cells with 
mucin-rich 
cytoplasm
NA NA NA Papillary 
mucous 
gland 
adenoma
Romagosa et al. (18) 
pt no. 1
F 33 Cough, fever, 
mucopurulent 
expectoration, 
shortness of breath
NA Intrabronchial 
polypoid mass
Left main bronchus NA NA Cells with 
bland 
nuclei, wide 
cytoplasm, 
and 
intranuclear 
inclusions; 
minor 
population 
of mucus-
secreting cells
NA NA Negative for 
malignancy
NA MEC 
(low-grade)
Romagosa et al. (18) 
pt no. 2
F 39 Incidental finding on 
chest X-ray
Right lower lobe 
mass
NA Right lower lobe NA Cells with 
bland 
nuclei, wide 
cytoplasm, 
and 
intranuclear 
inclusions; 
minor 
population 
of mucus-
secreting cells
NA NA NA Negative for 
malignancy
NA MEC 
(low-grade)
Qiu et al. (19) pt no. 1 M 51 Left chest and 
shoulder pain, fever, 
leg swelling
Atelectasis of left 
upper lobe
Endobronchial 
mass
Left upper lobe 
bronchus
1 NA AdCC NA NA NA NA AdCC
Florentine et al. (20) pt 
no. 1
F 85 NA NA Obstructing  
tumor
Left main  
bronchus
NA NA NA NA Carcinoid 
tumor or 
AdCC
NA NA AdCC
Chuah et al. (21) pt 
no. 1
M 44 Throat irritation, 
persistent cough
Mass lesion Polypoid tumor  
in bronchial  
lumen
Left hilum NA NA NA NA Carcinoma 
consistent 
with AdCC
NA NA AdCC
Daneshbod et al. (22) 
pt no. 1
F 55 Increasing shortness 
of breath, productive 
cough
Mass lesion NA Left lower lobe NA NA NA ? ? NA NA AdCC
(Continued)
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reference sex age Presentation radiology 
findings
bronchoscopy 
findings
site lesion 
size 
(cm)
Preoperative cytology Frozen 
section
histologic 
diagnosis
FNA (TT) FNA (TM) BB BW/TW Sputum
Daneshbod et al. (22) 
pt no. 2
65 Progressive 
breathlessness, 
productive cough
Collapse of the 
right lung
Carinal tumor 
extending in 
major bronchi
Carina + adjacent 
stem bronchi
NA NA NA NA ? Negative for 
malignancy
NA AdCC
Özkara and Turan (23) 
pt no. 1
M 54 Cough, expectoration, 
hemoptysis, chest 
pain, and weight loss
Opacity of left 
upper lobe  
(X-ray)
Shiny, sessile, 
polypoid mass
Left mainstem 
bronchus
4 NA AdCC, other 
than classical 
type
NA NA NA NA AdCC, 
solid 
variant
Endobronchial 
mass lesion (CT)
Chon et al. (24) pt no. 1 F 46 Incidental finding on 
chest X-ray
Right upper lung 
mass
NA Right upper lobe NA AdCC NA NA NA Negative for 
malignancy
NA AdCC
Dyhdalo and Chen (25) 
pt no. 1
F 45 Productive cough Well-
circumscribed 
nodule (CT)
NA Right lower lobe 
bronchus
NA NA Low-grade 
epithelial 
neoplasm, 
favor a low- 
grade 
bronchial 
MEC
NA NA NA NA MEC 
(low-grade)
Kim et al. (7) pt no. 1 M 42 NA Bronchial 
narrowing
NA Lymph node 1R NA NA NA NA Metastatic 
carcinoma 
from  
trachea
NA NA AdCC
Kim et al. (7) pt no. 2 F 47 NA Endobronchial 
tumor infiltration
NA Left main  
bronchus
NA NA NA NA Positive for 
malignant 
cells
NA NA AdCC
Kim et al. (7) pt no. 3 M 52 NA Bronchial 
obstruction
NA Lymph node, 7 NA NA Metastatic 
AdCC from 
lung
NA NA NA NA AdCC
Kim et al. (7) pt no. 4 F 61 NA NA NA Trachea NA NA AdCC  
cannot be 
excluded
NA NA NA NA AdCC
Kim et al. (7) pt no. 5 M 57 NA Bronchial 
obstructing  
mass
NA Right lower 
bronchus
NA NA NA NA A nest of 
atypical  
cells
NA NA AdCC
Kim et al. (7) pt no. 6 M 65 NA Tracheal 
obstruction
NA Carina NA NA NA NA Atypical  
cells
NA NA AdCC
Kim et al. (7) pt no. 7 F 75 NA Bronchial 
narrowing
NA Left main  
bronchus
NA NA NA NA Suspicious 
for 
malignancy
NA NA AdCC
Kim et al. (7) pt no. 8 M 60 NA Bronchial 
obstruction
NA Right upper 
bronchus
NA NA NA NA Suspicious 
for 
malignancy
NA NA AdCC
Kim et al. (7) pt no. 9 M 53 NA Tracheal mass NA Trachea NA NA NA NA AdCC 
cannot be 
excluded
NA NA AdCC
Table 2 | continued
(Continued)
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Mucoepidermoid carcinoma is the most common type of 
primary PSGT and it accounts for only 0.1–0.2% of all lung 
cancers (2, 28). In the majority of cases, it develops as an endo-
bronchial lesion located in the central airways, namely trachea, 
carina, and main stem bronchi; less than 6% of patients present 
with a peripheral lung nodule (3, 28, 29). Prognosis of pulmonary 
MEC is significantly better than that of non-small cell lung cancer 
(NSCLC) and small cell lung cancer (SCLC). Five-year survival 
of these three entities is 88, 21 and <5%, respectively (30). When 
they are divided into high-grade and low-grade tumors, bronchial 
MEC show a 5-year survival of 31 and 80%, respectively (31). 
The cytological features of LRT MEC, which can be diagnosed by 
FNA, BB, BA, BW, and BAL, overlap those of their salivary gland 
counterpart. Three cell types should be identified from MEC 
histology: mucin-secreting, squamous, and intermediate cells, 
which can be organized in different architectural patterns (32). 
Low-grade tumors show cystic zones consisting of cytologically 
bland mucin-secreting cells and solid areas composed of squamous 
or intermediate cells. Mitoses and necrosis are rare. High-grade 
tumors mainly consist of atypical squamous and intermediate 
cells, accompanied by variable numbers of mucin-secreting cells; 
necrosis; and mitoses are frequent (Figures 1A,B) (3). On cyto-
logical specimens, various combinations of mucin-producing, 
squamous, and intermediate cells have been observed according 
to tumor grade, with the characteristic admixture of all three cell 
types being helpful for recognition of this entity (Figures 1C–F) 
(9, 14, 25): typical non-keratinized squamous cells show round 
nuclei and moderate cytoplasm; mucinous cells are variable in 
shape, have small uniform nuclei and prominent nucleoli, and 
may contain a single vacuole that displaces the nucleus; inter-
mediate cells have well-defined homogeneous cytoplasm and 
small round nuclei with small nucleoli (25). Published cytological 
literature concerning primary pulmonary MEC shows that only 
Tao and Robertson and Brooks et al. have reported the presence of 
three distinct cell types (9, 14); all of the other authors described 
at best only two different cellular populations (Table 3) (11, 16, 
18, 25). Other features encountered on MEC histology, such as 
the presence of intranuclear inclusions and clear cell change, have 
been occasionally described on cytology (18).
Adenoid cystic carcinoma also generally arises as an endo-
bronchial tumor in central airways (Figures  2A,B); only spo-
radically is it reported in a peripheral lung location (4). Primary 
pulmonary AdCC is composed of two main cell types, ductal 
and modified myoepithelial cells, and can present three main 
architectural patterns, in keeping with salivary AdCC: cribriform, 
tubular, and solid (1, 4). Cytological findings include cohesive 
clusters of repetitive medium-sized cells, with scant cytoplasm 
and uniform, small, hyperchromatic nuclei containing a finely 
granular, evenly distributed chromatin (Figures  2C–F). Tumor 
cells are often arranged around a central core of homogeneous 
myxoid material, or form three-dimensional, “ball-like” clusters 
(Table 4) (10–13, 15, 19–22, 24, 26, 33). All of these features that 
recapitulate the histopathology of AdCC are helpful in correctly 
orienting the cytological diagnosis of this neoplasm. Sometimes, 
isolated hyaline globules can be observed (7, 20, 24, 26); singly 
dispersed cells are present on some smears (11, 26). The base-
ment membrane material, forming globules that have a light blue 
FigUre 1 | histological and cytological aspects of primary mucoepidermoid carcinoma (Mec) of the lower respiratory tract. (a) Histologically, in case 
9, diagnosed as a high-grade MEC, both squamous cells (arrow) and mucin-secreting cells (asterisk) are visible (Hematoxylin and Eosin, 400×). (b) Mucin-secreting 
cells are highlighted by Blue-Alcian stain. Small cystic spaces are also observed, even if these are more characteristic of low grade MEC (Blue-Alcian, 400×). 
 (c) Cytologically, in the bronchial brushing of the same patient, atypical cells were recognized as intermediate cells after slide revision. These cells have a high 
nuclear/cytoplasmic ratio (Papanicolaou staining, 400×). (D) Squamous cells were also identified during revision of the slides, demonstrating atypical nuclei and 
more abundant cytoplasm. The inset shows cells with keratinizing cytoplasm (Papanicolaou staining, 400×). (e,F) Admixed intermediate cells (arrow) and 
mucin-secreting cells (asterisk); the abundance of mucin-secreting cells was the basis for diagnosis of adenocarcinoma on cytology (e) (Papanicolaou  
staining, 400×) (F) (Papanicolaou staining, 600×).
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appearance on PAP stain and bright magenta on MGG stain, is 
the characteristic feature of AdCC; diagnostic difficulties arise 
when they are not present on cytological material, as the pattern 
could mimic carcinoid tumor, SCLC, NSCLC, and reserve cell 
hyperplasia (19).
Retrospectively, a correct preoperative diagnosis of all AdCC 
could have been rendered, because characteristic tridimensional 
clusters and hyaline globules were present on the smears; the hya-
line globules were confused with a metastatic breast carcinoma 
in the original diagnosis of one case and considered suspicious 
for carcinoma, NOS, in the other. Considering MEC, only one 
additional case could have been identified. The cytological 
diagnosis of MEC was possible since all the three diagnostic 
cellular components were present with features of malignancy 
(i.e., squamous, glandular, and intermediate cells). When look-
ing carefully at the smears, it was possible to identify aggregates 
of medium-sized cells that were bigger than basal and reserve 
bronchial cells. In the original cytological diagnosis, these 
intermediate cells were considered as suspicious for a carcinoma, 
NOS. Of note, in this case, an Alcian Blue staining was performed 
to identify glandular neoplastic cells, but only normal bronchial 
mucous cells were seen. Retrospective analysis revealed that the 
cells defined as “normal bronchial cells,” which stained positive for 
Blue-Alcian, were actually atypical. This allowed the retrospective 
diagnosis of MEC. In the remaining cases, the criteria for MEC 
were not fulfilled and only a poorly differentiated carcinoma 
could be diagnosed.
Immunocytochemistry is of limited value in diagnosing PSGT 
of the LRT. If these histological subsubtypes are not considered, 
only traditional markers of NSCLC subtyping are used. While 
epithelial cells of MEC and ductal cells of AdCC are positive 
for common epithelial markers (such as CK7 and CK 5/6) and 
Table 3 | cytomorphological features of primary pulmonary mucoepidermoid carcinoma (Mec) reported in the literature.
reference architecture background cell shape cytoplasm nuclei chromatin nucleoli
Tao and 
Robertson (9)
Tissue fragments with 
connective tissue core
ND Spindle cells Scanty Ovoid Finely 
granular, 
evenly 
distributed
Conspicuous 
in some cells
Epidermoid cells Apparent but not 
abundant
Round Finely 
granular, 
evenly 
distributed
Conspicuous, 
prominent
Mucus-secreting cells Containing a large 
mucous vacuole
Round ND ND
Nguyen (11) Single cells or small 
aggregates
Basophilic 
mucus-like 
material
Squamous cells (highly atypical) ND Large ND Prominent
Mucus-secreting cells Abundant, vacuolated Small, vesicular ND ND
Brooks and 
Baandrup (14)
Small tissue fragments 
with papillary projections
ND Polygonal cells ND Round or ovoid Finely 
dispersed
Not prominent
Occasional groups with 
fibrovascular core
Mucinous cells Foamy, clear ND ND ND
Squamous cells Abundant, dark blue, 
hyaline
Round, central ND ND
Segletes  
et al. (16)
ND Clean Glandular cells Delicate Eccentrical ND ND
Squamoid/intermediate cells Dense Central ND ND
Romagosa 
et al. (18)
Cells either grouped in 
irregular aggregates or 
singly dispersed in  
mucin
Slightly 
mucinous
Epidermoid cells (with clear cell 
change)
Wide, loose, poorly 
defined
Round, 
intranuclear 
inclusions
Finely 
granular
ND
Mucus-secreting cells ND ND ND ND
Dyhdalo and 
Chen (25)
Tight clusters Extracellular 
mucus 
material
Small, bland cells ND Central, round, 
uniform
ND Small
Glandular cells Vacuoles with mucin ND ND ND
ND, not described.
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p63 and p40 are expressed in all the intermediate and squamous 
cell component of MEC, myoepithelial cells of AdCC are usu-
ally positive for smooth muscle actin, vimentin, myosin, S-100, 
and for p63. Thus, CK7, CK5/6, p63, and p40 are potentially 
misleading markers as they are also part of the immunocyto-/
histochemical panel used to classify lung carcinomas. Their posi-
tivity would lead to a diagnosis of primary lung squamous cell 
carcinoma, rather than pointing to the presence of a squamous 
cell component in MEC or to the myoepithelial differentiation 
typical of AdCC (34, 35).
Besides these more common entities, other rarer PSGT of 
the LRT include acinic cell carcinoma, PA with its malignant 
counterpart carcinoma ex PA, myoepithelioma and myoepithelial 
carcinoma, mucous gland adenoma, and oncocytoma (1, 33, 36, 
37). No cytological description of such lesions in the LRT has 
been reported. Recently, a case of a primary pulmonary mucin-
rich variant of salivary duct carcinoma with preoperative cytology 
was published: BAL revealed cytologic atypia, and the right upper 
lobe bronchial brushing was positive for carcinoma. However, 
ICC was not performed due to the paucity of diagnostic mate-
rial and a conclusive diagnosis was not reached on cytological 
material (38). MASC, a rare salivary gland tumor first described 
in 2010, has never been described as a primary lung neoplasm 
(39). While reviewing the cytological and histological slides for 
our study, we paid particular attention to the identification of 
features that could point to a diagnosis of MASC, which we did 
not observe. No features resembling acinic cell carcinomas, that 
could have warranted (on cytological as well as on histological 
material) an immunocytochemical analysis for mammaglobin 
or FISH/molecular analysis for ETV6-NTRK3 translocation or 
ETV6 break, were seen (40, 41). ETV6-NTRK3 translocation or 
ETV6 breaks are present in up to 80 and 99% of MASC cases, 
respectively, and are quite specific for this entity (8).
In recent years, in addition to this molecular feature char-
acteristic of MASC, other diagnostic molecular signatures 
have been described for salivary gland tumors, even the ones 
developing in the LRT, and some with a high prevalence and 
discrete specificity (8, 34, 35, 42). With respect to MEC, specific 
translocations involving the CRTC1 gene and MAML2 or CRTC3 
and MAML2 have been described, with frequencies up to 80 and 
6% respectively (8, 43, 44). AdCC is characterized by a specific 
translocation, namely MYB/NFIB, present in up 90% of cases 
(8, 45). This translocation results in MYB protein overexpression 
that can be detected using IHC (46, 47). This test can be particu-
larly useful to confirm the diagnosis of AdCC, especially when 
combined with c-KIT (CD117) positivity, and can be applied on 
cytological smears. However, immunohistochemical staining for 
CD117 cannot be used alone in differential diagnosis of salivary 
gland neoplasms, because AdCC, PA, polymorphous low-grade 
adenocarcinoma, and monomorphic adenoma have all been 
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found to be positive, to differing degrees, for CD117. The use of 
a panel of immunomarkers including MYB, CD117, and the zinc 
finger protein PLAG1 (PA gene 1), quite specific for PA, is more 
judicious and very effective (46–48). A search for the EGFR muta-
tions was performed on the resected specimens of only one of our 
AdCC cases, which gave a negative result. Usually these tumors 
do not have EGFR mutations (49), although one case of AdCC 
with EGFR mutations has recently been reported (50). In our 
series (MEC and AdCC), molecular techniques could have been 
applied on cytological material in the case of diagnostic doubt, 
in order to detect these specific molecular alterations. However, 
apart the search for the EGFR mutation that has been done for 
therapeutic reasons, no molecular test was originally performed, 
not even for more recent cases. This supports the hypothesis that 
a diagnosis of primary PSGT was not considered.
cOnclUsiOn
An awareness of the possibility of encountering primary PSGT 
in the cytological specimens of patients investigated for LRT 
masses is fundamental to establishing a correct diagnosis. This is 
particularly relevant for AdCC, as all cases reported in literature 
showed characteristic cytological features that could have allowed 
a correct preoperatory diagnosis. As far as MEC is concerned, 
its preoperative diagnosis is more difficult, as the three different 
cellular components (i.e., squamous, intermediate, and mucin-
secreting cells) were not always reported to be present on cytol-
ogy specimens. In cases that raise suspicion of AdCC or MEC, 
additional immunohistochemical (MYB, c-kit) or molecular 
techniques (e.g., FISH) could be applied to cytological smears to 
refine the diagnosis.
FigUre 2 | Macroscopic, histological, and cytological aspects of primary adenoid cystic carcinomas (adcc) of the lower respiratory tract. 
 (a) Macroscopic presentation of the 2.5-cm lesion in the distal carina of case 1. Inset shows the almost complete obliteration of the lumen of the bronchus 
(Hematoxylin and Eosin, scan of the slide). (b) Bronchial biopsy of case 4 demonstrates the typical cribriform and tubular pattern of AdCC (Hematoxylin and Eosin, 
20×). (c) Ovoid structures constituted by monotonous cells surrounding a central lumen (“ball-like” clusters) that were considered as metastatic ductal breast 
carcinoma cells in case 2 (Papanicolaou staining, 200×). Inset shows the tubular architecture of the same case, exactly reflecting the cytological findings, which were 
correctly interpreted as primary AdCC on histology (Hematoxylin and Eosin, 20×). (D) Tubular structures comprised of repetitive medium-sized cells with scant 
cytoplasm and hyperchromatic nuclei containing a finely granular chromatin, containing a central core of homogeneous material. Note the inner layer of ductal cells and 
outer layer of myoepithelial cells (Papanicolaou staining, 400×). (e) The same cell types with scant pale-staining cytoplasm are arranged around hyaline globules in 
close proximity to each other (Papanicolaou staining, 400×). (F) Occasionally, the hyaline matrix is easily detected and is deprived of cells (Papanicolaou staining, 400×).
11
S
aglietti et al.
C
ytology of P
S
G
T of the LR
T
Frontiers in M
edicine | w
w
w
.frontiersin.org
A
pril 2017 | Volum
e 4 | A
rticle 43
Table 4 | cytomorphological features of primary pulmonary adenoid cystic carcinoma (adcc) reported in the literature.
reference architecture background cell shape cytoplasm nuclei chromatin nucleoli
Lozowski  
et al. (10)
Cyst-like structures filled with dense, pink-staining, amorphous material (rarely) Pinkish-
staining, 
mucous, 
granular 
background
ND ND Uniform, small,  
ovoid
Finely granular, 
evenly  
distributed
ND
Buchanan  
et al. (12)
Cohesive clusters of cells with central cystic spaces filled with amorphous, hyaline material ND ND Minimal Uniform, small,  
ovoid
Finely granular, 
bland
ND
Three-dimensional, ball-like formations
Nguyen (11) Single and clustered tumor cells ND Cuboidal Scanty Round, 
hyperchromatic
ND ND
Gland-like spaces filled with pinkish mucus-like material
Gupta and 
McHutchison (13)
Cohesive three-dimensional clusters of cells; cystic spaces containing cyanophilic 
amorphous material
ND Uniform Minimal Uniform, small,  
ovoid
Finely granular ND
Radhika et al. (15) Mucoid globules surrounded by malignant cells ND Cylindroid/ 
tubular
Scanty Hyperchromatic ND ND
Solid clusters of cells
Segletes et al. (16) Tightly cohesive aggregates Clean Small, uniform Scant, delicate, 
non-vacuolated
Ovoid, high nuclear/
cytoplasmic ration
Finely granular, 
evenly 
distributed,  
darkly stained
ND
Clusters of cells including central acellular spheres of dense, homogeneous material
Özkara and  
Turan (23)
Three-dimensional clusters of neoplastic basaloid cells associated with hyaline basement 
membrane material
Bloody Homogeneous, 
small
Modest, 
eosinophilic
Small,  
hyperchromatic
ND ND
Qiu et al. (19) Three-dimensional clusters of neoplastic basaloid cells associated with hyaline material  
forming cylinders or spheres
ND ND ND ND ND ND
Aggregates of neoplastic basaloid cells with scanty or no amorphous material
Florentine  
et al. (20)
Scattered sheets and ball-like clusters of tumor cells ND Small, basaloid Scanty Round ND ND
Hyaline globules at times surrounded by neoplastic cells
Chuah et al. (21) Solid sheets and gland-like spaces associated with mucoid material ND Monomorphic ND ND ND ND
Tight, branching clusters with tubular appearance
Daneshbod et al. 
(22)
Cell clusters associated with myxoid, hyaline material ND Dimorphic 
appearance of 
tumor cells
ND ND ND ND
Chon et al. (24) Tight clusters, globules of acellular mucoid material ND Monomorphic, 
basaloid
ND Round to oval Fine granular Indistinct
Bhalara et al. (26) Poorly cohesive clusters and complex sheets ND ND Scanty Monomorphic,  
bland,  
hyperchromatic
ND ND
Homogeneous hyaline globules
Singly dispersed cells
Kim et al. (7) Organoid clusters ND Small, uniform, 
hyperchromatic
Granular ND ND Distinct
Sheet formation
Hyaline globules
ND, not described.
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